Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease
GW Ross, H Petrovitch - Drugs & aging, 2001 - Springer
Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting
1 to 3% of individuals over the age of 65 years. While effective therapy exists for treating the …
1 to 3% of individuals over the age of 65 years. While effective therapy exists for treating the …
Central nicotinic receptors, neurotrophic factors and neuroprotection
N Belluardo, G Mudò, M Blum, K Fuxe - Behavioural brain research, 2000 - Elsevier
The multiple combinations of nAChR subunits identified in central nervous structures posses
distinct pharmacological and physiological properties. A growing number of data have …
distinct pharmacological and physiological properties. A growing number of data have …
[HTML][HTML] Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease
I Moreno-Gonzalez, LD Estrada… - Nature …, 2013 - nature.com
Several epidemiological studies have shown that cigarette smoking might alter the
incidence of Alzheimer's disease. However, inconsistent results have been reported …
incidence of Alzheimer's disease. However, inconsistent results have been reported …
Disease-modifying drugs in Alzheimer's disease
L Ghezzi, E Scarpini, D Galimberti - Drug design, development and …, 2013 - Taylor & Francis
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most
common cause of dementia. The early stages of AD are characterized by short-term memory …
common cause of dementia. The early stages of AD are characterized by short-term memory …
PASS assisted prediction and pharmacological evaluation of novel nicotinic analogs for nootropic activity in mice
The aim of present study is to predict the probable nootropic activity of novel nicotine
analogues with the help of computer program, PASS (prediction of activity spectra for …
analogues with the help of computer program, PASS (prediction of activity spectra for …
Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation
S Ge, JA Dani - Journal of Neuroscience, 2005 - Soc Neuroscience
The hippocampus is a center for learning and memory that receives abundant cholinergic
innervation and richly expresses nicotinic acetylcholine receptors (nAChRs). Nicotinic …
innervation and richly expresses nicotinic acetylcholine receptors (nAChRs). Nicotinic …
Autonomic imbalance and immune activation in chronic heart failure–pathophysiological links
Activation of the immune system and derangement of cardiorespiratory neural control are
established elements of the complex pathophysiology of chronic heart failure (CHF). The …
established elements of the complex pathophysiology of chronic heart failure (CHF). The …
Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback
LM Giocomo, ME Hasselmo - Molecular neurobiology, 2007 - Springer
Substances such as acetylcholine and glutamate act as both neurotransmitters and
neuromodulators. As neuromodulators, they change neural information processing by …
neuromodulators. As neuromodulators, they change neural information processing by …
High selective expression of α7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670 …
WF Yu, ZZ Guan, N Bogdanovic, A Nordberg - Experimental neurology, 2005 - Elsevier
In the present study, we have investigated the expression of nicotinic acetylcholine receptors
(nAChRs) on astrocytes and neurons in the hippocampus and temporal cortex of subjects …
(nAChRs) on astrocytes and neurons in the hippocampus and temporal cortex of subjects …
A 2‐year follow‐up study of cigarette smoking and risk of dementia
D Juan, DHD Zhou, J Li, JYJ Wang… - European Journal of …, 2004 - Wiley Online Library
The report focused on investigating the relationship between cigarette smoking and
dementia in elderly people through prospective studies. We did a 2‐year follow‐up study of …
dementia in elderly people through prospective studies. We did a 2‐year follow‐up study of …